XRGenomics has significant capacity in the field of personalized medicine, including RNA based diagnostic technologies for geriatric medicine and clinical prognosis. We focus on the development of RNA diagnostics to provide advanced warning for chronic diseases, such dementia and pre-diabetes because measures of RNA capture more clinically useful and actionable information than other types of genomic technology
Management Team
Prof Jamie Timmons PhD – Director and CSO
jamie.timmons@xrgenomics.com
Jamie founded XRGenomics in 2012 on the back of a decade of OMIC work carried out at the Karolinska Institutet. Trained in biomedical sciences, metabolism and genomics he has spent the last decade raising >£10 million for personalized medicine projects. Jamie also works part-time as a Professor in Precision Medicine, King's College London.
Mr Gordon Farquhar – COO
Gordon.farquhar@xrgenomics.com
Gordon has two decades of experience in management strategy and consulting. A graduate from Strathclyde University, Glasgow, Gordon has worked with major international companies, such as British Airways and Royal Bank of Scotland, solving complex logistic and technology related challenges
Dr Niels Vollaard PhD – Director
niels.vollaard@xrgenomics.com
Niels qualified with multiple post-graduate degrees in physiology and nutrition. A lead investigator on the EU metapredict study (www.metapredict.eu) Niels is an expert in human physiology and clinical data analysis
Intellectual Property Advisors
Mr Robert Gleave, Patent Attorney
robert.gleave@collerip.com
Wallingford, Oxfordshire
Accountants
Mr Kevin Varney
kevin.varney@varneybarfield.co.uk
Varney Barfield and Company
Corunna Road, Warwick, CV34 5HQ
VAT number 139 6153 01
European Union Research PIC number is 949388471